juanwallabite
@juanwallabite
11 Years
Comments: 0 · Posts: 1 · Topics: 1
Discover insights, swap stories, and find people. dxpnet is where experiences turn into understanding.
Create Your Free Account →We use cookies to enhance your experience. By continuing to browse, you agree to our use of cookies. Policy Page
—There are a lot of barriers for patients who are poor and have a low health literacy. We??re really hoping that patient navigation is the solution,?? said Dr. Naomi Ko, who led the study at Boston University School of Medicine.
—We really need to figure out why it helps and where it helps. And if we can do that right, we have the potential to help a lot of needy, vulnerable, low-income minority patients get the right and timely care,?? Ko told Reuters Health.
She and her team examined the records of 1,288 racially diverse women diagnosed with breast cancer at eight centers across the U.S. Roughly half of the women were assigned navigators and the rest were not.
The researchers sought to determine whether women with navigators might be more likely to get guideline-recommended treatment. Based on women??s age and the type and size of their breast tumors, that treatment included anti-estrogen therapy, radiation or chemotherapy.
Participants eligible for anti-estrogen therapy had a 73 percent greater chance of getting that treatment when they had a navigator. That was after taking into account other potential differences between women, such as their age, ethnicity, language, insurance and treatment site.
The finding was particularly promising because poor, minority women can have low levels of use of anti-estrogen therapy, the authors write in the Journal of Clinical Oncology. The medication treats hormone-receptor-positive breast cancer by lowering estrogen levels and blocking estrogen??s ability to act on breast cancer cells.
Navigators, however, did not seem to influence whether women received radiation after breast-conserving surgery. And at the four sites where the authors could estimate the effect of navigators on chemotherapy, patients with navigators were less likely to get recommended chemo.
—We think patient navigation helps, but we don't know where it helps and how it helps,?? Ko said. —There are still a lot of questions.??
http://www.california-mesothelioma.net/guide-patients-breast-cancer/